
Valion Bio’s Entolimod Gains Clinical Foothold in Oncology
Sheba Medical Center, ranked among the world’s top ten hospitals, has launched a clinical trial of Valion Bio’s Entolimod to address radiation-induced neutropenia. This move marks a strategic pivot for the drug, transitioning it from specialized biodefense applications into the broader, multi-billion-dollar market for supportive oncology care.

























